Lipidor Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 5

Employees

  • Stock Symbol
  • LIPI

Stock Symbol

  • Investments
  • 2

Lipidor General Information

Description

Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Contact Information

Website
www.lipidor.se
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
STO
Corporate Office
  • Svardvagen 13
  • 182 33 Danderyd
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipidor Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$553K 73.3M 600K -$0.02

Lipidor Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,269 1,210 365 19,815
Revenue 8 7 4 1,790
EBITDA (1,003) (1,006) (4,061) (2,477)
Net Income (1,093) (1,081) (4,079) (2,479)
Total Assets 165 283 1,497 6,080
Total Debt 49 53 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lipidor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lipidor‘s full profile, request access.

Request a free trial

Lipidor Patents

Lipidor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014349257-A1 Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine Inactive 14-Nov-2013 0000000000
EP-3068436-A1 Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine Inactive 14-Nov-2013 0000000000
CA-2929867-A1 Composition and method for topical treatment Inactive 14-Nov-2013 0000000000
EP-3068436-A4 Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine Inactive 14-Nov-2013 0000000000 0
ES-2745093-T3 Sprayable topical carrier and composition comprising phosphatidylcholine Active 14-Nov-2013 A61K47/24
To view Lipidor’s complete patent history, request access »

Lipidor Executive Team (8)

Name Title Board Seat Contact Info
Ola Holmlund Chief Executive Officer
Charlotta Ekman Chief Financial Officer
Jan Holmbäck Ph.D Co-Founder & Chief Scientific Officer
Bengt Herslöf Ph.D Co-Founder
You’re viewing 4 of 8 executive team members. Get the full list »

Lipidor Board Members (6)

Name Representing Role Since
Fredrik Sjövall Self Board Member 000 0000
Magnus Hedman Self Board Member 000 0000
Ola Flink Lipidor Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Lipidor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipidor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lipidor‘s full profile, request access.

Request a free trial

Lipidor Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Emollivet 15-Mar-2022 00000 (000 00000 Other Consumer Non-Durables 0000000 0
Emollivet 30-Jun-2020 Angel (individual) 00000 Other Consumer Non-Durables
To view Lipidor’s complete investments history, request access »

Lipidor FAQs

  • When was Lipidor founded?

    Lipidor was founded in 2009.

  • Who is the founder of Lipidor?

    Anders Carlsson Ph.D, Jan Holmbäck Ph.D, Bengt Herslöf Ph.D, and Olle Holmertz are the founders of Lipidor.

  • Who is the CEO of Lipidor?

    Ola Holmlund is the CEO of Lipidor.

  • Where is Lipidor headquartered?

    Lipidor is headquartered in Danderyd, Sweden.

  • What is the size of Lipidor?

    Lipidor has 5 total employees.

  • What industry is Lipidor in?

    Lipidor’s primary industry is Biotechnology.

  • Is Lipidor a private or public company?

    Lipidor is a Public company.

  • What is Lipidor’s stock symbol?

    The ticker symbol for Lipidor is LIPI.

  • What is the current market cap of Lipidor?

    The current market capitalization of Lipidor is $553K.

  • What is Lipidor’s current revenue?

    The trailing twelve month revenue for Lipidor is $8.2K.

  • What is Lipidor’s annual earnings per share (EPS)?

    Lipidor’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »